QLIFE Stock Overview
A med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Qlife Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.10 |
| 52 Week High | SEK 49.20 |
| 52 Week Low | SEK 1.30 |
| Beta | 0.85 |
| 1 Month Change | -3.67% |
| 3 Month Change | -15.32% |
| 1 Year Change | -94.29% |
| 3 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
| QLIFE | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.5% | 0.4% | 0.7% |
| 1Y | -94.3% | -9.4% | 6.3% |
Return vs Industry: QLIFE underperformed the Swedish Medical Equipment industry which returned -9.4% over the past year.
Return vs Market: QLIFE underperformed the Swedish Market which returned 6.3% over the past year.
Price Volatility
| QLIFE volatility | |
|---|---|
| QLIFE Average Weekly Movement | 13.0% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 11.5% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: QLIFE's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: QLIFE's weekly volatility has decreased from 23% to 13% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 5 | Thomas Warthoe | www.qlifeholding.com |
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus.
Qlife Holding AB (publ) Fundamentals Summary
| QLIFE fundamental statistics | |
|---|---|
| Market cap | SEK 5.31m |
| Earnings (TTM) | -SEK 160.96m |
| Revenue (TTM) | SEK 69.00k |
76.9x
P/S Ratio0.0x
P/E RatioIs QLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QLIFE income statement (TTM) | |
|---|---|
| Revenue | SEK 69.00k |
| Cost of Revenue | SEK 3.32m |
| Gross Profit | -SEK 3.25m |
| Other Expenses | SEK 157.71m |
| Earnings | -SEK 160.96m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | -63.66 |
| Gross Margin | -4,710.14% |
| Net Profit Margin | -233,279.71% |
| Debt/Equity Ratio | 4,334.7% |
How did QLIFE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 02:48 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Qlife Holding AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carl Ramanius | Redeye |